Vanderwinden JM. Pyloric stenosis. N Engl J Med. 1992;327:511–515.
Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 Suppl II: 43–47.
Frissora C, Harris L. Choosing the appropriate oral contraceptive is part of the treatment of functional nausea in women [Abstract]. Am J Gastroenterol. 2001;96.
American Gastroenterological Association. Medical position statement: irritable bowel syndrome. Gastroenterology. 1997; 112:2118–2119.
Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 2000; 46:78–82.
Gralnek IM, Hays RD, Kilbourne A, et al. The impact of the irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–660.
Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142:76–83.
Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580.
Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109:40–52.
McKendrick W, Read NW. Irritable bowel syndrome—post salmonella infection. J Infection. 1994;29:1–3.
Maxwell PR, Rink E, Kumar D, Mendall MA. Antibiotics increase functional abdominal symptoms. Am J Gastroenterol. 2002;97:104–108.
Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112:2120–2137.
Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989;96:981–988.
Green PHR, Stavropolos SN, Panagi SN, et al. Characteristics of adult celiac disease in the United States. Am J Gastroenterol. 2001;96:126–131.
Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet. 1987;1:963–965.
Levy RL, VonKorff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome in patients in a health maintenance organization. Am J Gastroenterol. 2001;96:3122–3129.
Periti P, Tonelli F. Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii. J. Chemo. 2001;13(5):529–549.
Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999;13:1149–1159.
Frissora CL. Bupropion (Wellbutrin) for smoking cessation increases well being in IBS patients [abstract]. J Gastroenterol. 2002; 97(9). In press.
DePonti R, Malagelada JR. Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther. 1998;80:49–88.
Toskes PP, Connery KL, Ritchey TW. Calcium polycarbophil compared with placebo in the irritable bowel syndrome. Aliment Pharmacol Ther. 1993;7:87–92.
Lembo T, Wright RA, Bagby B, et al. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea—predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96:2662–2670.
Wolfe SG, Chey WY, Washington MK, et al. Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients. Am J Gastroenterol. 2001;96:803–811.
Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5HT4 receptor partial agonist relieves symptoms in irritable bowel patient with abdominal pain, bloating and constipation. Aliment Pharmacol Ther. 2001;15:1655–1666.
Poynard T, Naveau S, Mory B, Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of the irritable bowel syndrome. Aliment Pharmacol Ther. 1994;8:499–510.
Clouse RE, Lustman PJ, Geisman RA, et al. Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther. 1994; 8:409–416.
Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med. 1992;116:1009–1016.